For research use only. Not for therapeutic Use.
| Catalog Number | R023408 |
| CAS Number | 111-58-0 |
| Synonyms | (Z)-N-(2-Hhydroxyethyl)-9-octadecenamide; N-(2-Hydroxyethyl)-oleamide; AM 3101; N-(2-Hydroxyethyl)-9-Z-octadecenamide; N-(2-Hydroxyethyl)oleamide; N-Oleoyl-2-aminoethanol; N-Oleoylethanolamide; N-Oleoylethanolamine; Oleamide MEA; |
| Molecular Formula | C20H39NO2 |
| Purity | ≥95% |
| Target | Vitamin D Related/Nuclear Receptor |
| Solubility | Soluble in DMSO，methanol or 100% ethanol |
| Storage | Store at +4C |
| IUPAC Name | (Z)-N-(2-hydroxyethyl)octadec-9-enamide |
| InChI | InChI=1S/C20H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-20(23)21-18-19-22/h9-10,22H,2-8,11-19H2,1H3,(H,21,23)/b10-9- |
| InChIKey | BOWVQLFMWHZBEF-KTKRTIGZSA-N |
| SMILES | CCCCCCCCC=CCCCCCCCC(=O)NCCO |
| Reference | <br>1. A. Spinedi et al. “N-Oleoylethanolamine inhibits glucosylation of natural ceramides in CHP-100 neuroepithelioma cells: possible implications forapoptosis” Biochem Biophys Res Commun, vol. 255 pp. 456-459, 1999<br>2. A. Bielawska et al. “(1S,2R)-D-erythro-2-(N-Myristoylamino)-1-phenyl-1-propanol as an Inhibitor of Ceramidase” Journal of Biological Chemistry, vol.271 pp. 12646-12654, 1996<br>3. R. Capasso and A. Izzo “Gastrointestinal Regulation of Food Intake: General Aspects and Focus onAnandamide and Oleoylethanolamide” Journal of Neuroendocrinology, vol. 20 pp. 39-46, 2008<br>4. D. Koethe et al. “Sleep deprivation increases oleoylethanolamide in human cerebrospinal fluid” J Neural Transm, vol. 116 pp. 301-305, 2009</br></br></br></br> |
